Voronoi, Inc. (KOSDAQ:310210)
South Korea · Delayed Price · Currency is KRW 238,000
+6,000 (2.59%)
At close: Dec 5, 2025
Voronoi Revenue
Voronoi had revenue of 4.14B KRW in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 7.49B.
Revenue (ttm)
7.49B
Revenue Growth
n/a
P/S Ratio
571.62
Revenue / Employee
53.50M
Employees
140
Market Cap
4.28T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 9.77B | -5.02B | -33.93% |
| Dec 31, 2021 | 14.78B | 8.60B | 139.22% |
| Dec 31, 2020 | 6.18B | 5.88B | 1,955.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.50T |
| Celltrion | 3.90T |
| Yuhan | 2.14T |
| Hanmi Pharm. | 1.47T |
| SK Biopharmaceuticals | 675.41B |
| Sam Chun Dang Pharm. | 220.74B |
| ALTEOGEN | 202.18B |
| LigaChem Biosciences | 159.27B |